Moberg Pharma AB (publ)

OTCPK:MBGP.F Stock Report

Market Cap: US$49.7m

Moberg Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of MBGP.F?
Owner TypeNumber of SharesOwnership Percentage
Public Companies825,0001.76%
Private Companies1,000,0002.13%
Hedge Funds2,442,1875.2%
General Public7,178,16515.3%
Individual Insiders8,054,25517.1%
Institutions27,501,02058.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 81.15% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15%
IBG LLC
7,047,069US$7.5m0%0.77%
9.37%
Nordnet AB (publ)
4,403,813US$4.7m-2.28%0.4%
5.64%
Richard Ding
2,649,037US$2.8m0%no data
5.6%
Goldenwise Capital Group Ltd
2,633,399US$2.8m0%no data
5.2%
Noster Capital, LLP
2,442,187US$2.6m0%28.67%
5.1%
Skandinaviska Enskilda Banken AB (publ)
2,398,664US$2.5m0%0.02%
4.68%
Avanza Fonder AB
2,200,525US$2.3m-5.91%0.02%
4.24%
SEB Life International Assurance Company Designated Activity Company
1,993,997US$2.1m1.12%9.02%
4.1%
BNY Mellon Advisors, Inc.
1,929,086US$2.0m0%0.01%
2.82%
Citigroup Inc.
1,325,663US$1.4m0%no data
2.13%
Kjelsmark Holding ApS
1,000,000US$1.1m0%no data
1.97%
Fredrik Blom
926,000US$979.9k161%no data
1.82%
FMR LLC
855,850US$905.7k35.5%no data
1.76%
SEB SA
825,000US$873.0k0%0.02%
1.49%
Styrbjorn Zachau
700,000US$740.8k-90%no data
1.32%
Fredrik Åsberg
622,425US$658.7k0%no data
1.32%
Swedbank Robur Fonder AB
618,146US$654.1k-0.32%no data
1.18%
Chance Chen
555,000US$587.3k20.8%no data
1.06%
Dennis Pedersen
500,238US$529.4k0.32%no data
0.95%
Anders Obrink
444,873US$470.8k0%no data
0.94%
Clearstream Banking S.A.
442,539US$468.3k0%0.05%
0.9%
Saxo Bank A/S
423,843US$448.5k12.4%0.02%
0.88%
SEB Funds AB
414,091US$438.2k8.68%no data
0.85%
UBS Asset Management AG
400,000US$423.3k0%no data
0.83%
Beatrice Iveland
390,000US$412.7k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/04 22:03
End of Day Share Price 2026/06/02 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Moberg Pharma AB (publ) is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bjorn RydellABG Sundal Collier Sponsored
Klas PykNordea Markets
Mats HyttingeRedeye